Latest news
Loading news…
DeCODE Genetics is a biopharmaceutical company that develops and offers diagnostic tests for variants in genes.
DeCODE Genetics was acquired by Amgen in 2012 for $415M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
41
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Reykjavík, Gullbringusysla, Iceland
Acquisitions by DeCODE Genetics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at DeCODE Genetics
Founder and CEO
Vice President of Research
Vice President of Statistics
Vice President of Informatics
41
professional contacts at DeCODE Genetics
Contact execs at DeCODE Genetics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to DeCODE Genetics
Loading news…
FAQs about DeCODE Genetics
People who checked this page also checked these
Browse the full Acquirezy directory.